Lobe Sciences Ltd.
LOBE
CNSX
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 0.00 |
| Cost of Revenue | -- | -- | -- | 182.00K | 10.40K |
| Gross Profit | -- | -- | -- | -182.00K | -10.40K |
| SG&A Expenses | 2.90M | 2.42M | 2.54M | 1.73M | 1.46M |
| Depreciation & Amortization | -- | -- | -- | 0.00 | 20.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.88M | 3.58M | 3.01M | 2.12M | 1.64M |
| Operating Income | -4.88M | -3.58M | -3.01M | -2.12M | -1.64M |
| Income Before Tax | -5.11M | -3.85M | -3.50M | -3.92M | -3.43M |
| Income Tax Expenses | -- | -- | -- | 24.10K | 24.10K |
| Earnings from Continuing Operations | -5.11 | -3.85 | -3.50 | -3.95 | -3.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.04M | 592.80K | 313.70K | 107.00K | -- |
| Net Income | -4.08M | -3.26M | -3.19M | -3.84M | -3.45M |
| EBIT | -4.88M | -3.58M | -3.01M | -2.12M | -1.64M |
| EBITDA | -2.06M | -2.49M | -2.94M | -2.08M | -1.59M |
| EPS Basic | -0.73 | -0.72 | -0.73 | -0.18 | -0.18 |
| Normalized Basic EPS | -0.46 | -0.46 | -0.46 | -0.04 | -0.04 |
| EPS Diluted | -0.73 | -0.72 | -0.73 | -0.18 | -0.18 |
| Normalized Diluted EPS | -0.46 | -0.46 | -0.46 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 731.43M | 648.31M | 554.81M | 565.05M | 486.58M |
| Average Diluted Shares Outstanding | 731.43M | 648.31M | 554.81M | 565.05M | 486.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |